[1] SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2015[J].CA Cancer J Clin,2015,65(1):5-29.
[2] 王惠雪,李惠萍,杨娅娟,等.乳腺癌术后淋巴水肿预防行为相关临床实践指南现况及内容研究[J].中国全科医学,2017,20(6):639-644.
[3] 刘风华,胡艳,沈培佩,等.乳腺癌相关淋巴水肿发病情况及危险因素前瞻性队列研究[J].中华放射肿瘤学杂志,2016,25(6):593-597.
[4] PETREK J A,SENIE R T,PETERS M,et al.Lymphedema in a cohortof breast carcinoma survivors 20 years after diagnosis[J].Cancer,2001,92(6):1368-1377.
[5] CHANG E I,SCHAVERIEN M V,HANSON S E,et al.Evolution in Surgical Management of Breast Cancer-related Lymphedema:The MD Anderson Cancer Center Experience[J].Plast Reconstr Surg Glob Open,2020,8(3):e2674.
[6] 朱倩男,夏添松,凌立君,等.乳腺癌术后上肢淋巴水肿发生机制及预防进展[J/OL].中华乳腺病杂志(电子版),2013,7(6):442-445.
[7] 贾杰.规范乳腺癌术后上肢淋巴水肿的诊治流程[J].中国康复医学杂志,2018,33(4):375-378.
[8] KIM M,PARK I H,LEE K S,et al.Breast cancer-related lymphedema after neoadjuvant chemotherapy[J].Cancer Res Treat,2015,47(3):416-423.
[9] 黄婧慧,黄枫,朱佩,等.女性乳腺癌术后上肢淋巴水肿危险因素调查分析[J].康复学报,2019,29(5):5-9.
[10] 杨潜.乳腺癌腋窝淋巴结清扫术后上肢淋巴水肿的危险因素分析[D].上海:第二军医大学,2009:13-15.
[11] SANDRA M,CRISTIANE M N,IRIA B,et al.Lymphedema predictor factors after breast cancer surgery:a survival analysis[J].Lymphatic Res,2015,13(4):268-274.
[12] DOMINICK S A,MADLENSKY I,NATARAJAN L,et al.Risk factors associated with breast cancer-related lymphedema in the WHEL Study[J].J Cancer Surviv,2013,7(1):115-123.
[13] CLARK B,SITZIA J,HARLOW W.Incidence and risk of arm oedema following treatment for breast cancer:A three-year follow-up study[J].QJM,2005,98(5):343-348.
[14] KWAN M L,YAO S,LEE V S,et al.Race/ethnicity,ge netic ancestry,and breast cancer-related lymphedema in the Pathways Study[J].Breast Cancer Res Treat,2016,159(1):119-129.
[15] 马小开.乳腺癌患者腋窝淋巴结转移规律及上肢淋巴引流规律的临床研究[D].济南:山东大学,2019.
[16] GENCAY CAN A,EKSIOGLU E,BAHTIYARCA Z T,et al.As sessment of risk factors in patients who presented to the outpatient clinic for breast cancer-related lymphedema[J].J Breast Health,2016,12(1):31-36.
[17] KILBREATH S L,REFSHAUGE K M,BEITH J M,et al.Risk factors for lymphoedema in women with breast cancer:a large prospective cohort[J].Breast,2016,28:29-36.
[18] 孙文雯,刘海,董丽丽,等.连云港地区乳腺癌患者对术后淋巴水肿认知情况调查[J].中国临床研究,2020,33(6):856-859.
[19] 丰锦春,吴涛,吐鲁洪,等.乳腺癌腋窝淋巴结清扫术后上肢淋巴水肿的危险因素分析[J].现代诊断与治疗,2018,29(20):3250-3252.
[20] 汪海仪,夏飞,吴宝潮,等.不同病理分期和分子分型的乳腺癌患者行ARM后水肿发生率的相关性研究[J].东南大学学报(医学版),2018,37(4):607-611.
[21] KIM M,SHIN K H,JUNG S,et al.Identification of prognostic risk factors for transient and persistent lymphedema after multimodal treatment for breast cancer[J].Cancer Res Treat,2016,48(4):1330-1337.
[22] KIM M,KIM S W,IEE S U,et al.A model to estimate the risk of breast cancer-related lymphedema:combinations of treatment-related factors of the number of dissected axillary nodes,adjuvant chemotherapy,and radiation therapy[J].Int J Radiat Oncol Biol Phys,2013,86(3):498-503.
[23] RIBEIRO P A,KOIFMAN R J,BERGMANN A.Incidence and risk factors of lymphedema after breast cancer treatment:10 years of follow-up[J].Breast,2017,36:67-73.
[24] MILLER C L,SPECHT M C,SKOLNY M N,et al.Risk of lymphedema after mastectomy:potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients[J].Breast Cancer Res Treat,2014,144(1):71-77.
[25] RONKA R H,PAMILO M S,SMITTEN K A,et al.Breast lymphedemaafter breast conserving treatment[J].Acta Oncol,2004,43(6):551-557.
[26] BASTA M N,WU L C,KANCHWALA S K,et al.Reliable prediction of postmastectomy lymphedema:the risk assessment tool evaluating lymphedema[J].Am J Surg,2017,213(6):1125-1133.
[27] 曹欣华,吕建鑫,胡浩霖,等.不同手术方式对早期乳腺癌患者的术后恢复及并发症的影响[J].东南大学学报(医学版),2018,37(1):45-49.
[28] 赵树鹏,齐凤杰.乳腺癌改良根治术手术切口与术后并发症的相关性[J].中国现代医学杂志,2010,20(13):2031-2033.
[29] 杨杰,高明.乳腺癌术后上肢淋巴水肿危险因素的临床观察[J].浙江创伤外科,2015(1):114-116.
[30] 唐小乔,苏磊,桑剑锋.乳腺癌改良根治术后上肢淋巴水肿与腋窝淋巴结阳性率的相关性分析[J/OL].中华普外科手术学杂志(电子版),2020,14(1):74-77.
[31] BEVILACQUA J L B,KATTAN M W,YU C,et al.Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer[J].Ann of Surg Oncol,2012,19(8):2580-2589.
[32] 刘晓溪,王世宣.乳腺癌术后上肢淋巴水肿的发生因素分析与护理[J].护士进修杂志,2016,31(8):715-717.
[33] WARREN I E G,MILLER C L,HORICK N,et al.The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer:a prospective cohort study[J].Int J Radiat Oncol Biol Phys,2014,88(3):565-571.
[34] 谢玉环.乳腺癌相关上肢淋巴水肿危险因素荟萃分析[D].苏州:苏州大学,2015.
[35] AHMED R L,SCHMITZ K H,PRIZMENT A E,et al.Risk factors for lymphedema in breast cancer survivors,the Iowa Women's Health Study[J].Breast Can Res Treat,2011,130(3):98l-991.
[36] 王季,张意辉,张丽娟,等.体重指数及体重波动对乳腺癌患者上肢淋巴水肿的影响[J].中国康复医学杂志,2020,35(2):182-185.
[37] 严鹏,宫晨,黄燕,等.肌内效贴治疗乳腺癌根治术患者放疗后上肢肿胀的疗效观察[J].中华物理医学与康复杂志,2016,38(10):764-767.
[38] LIN T C,HSU C Y,WEN C W,et al.Effects of weight reduction on the breast cancer-related lymphedema:A systematic review and meta-analysis[J].Breast,2020,52:116-121.
[39] RYU E,YIM S Y,DO H J,et al.Risk of secondary lymphedema in breast cancer survivors is related to serum phospholipid fatty acid desaturation[J].Support Care Cancer,2016,24(9):3767-3774.
[40] 李晓平.Bevilacqua乳腺癌术后淋巴水肿风险预测模型的外验证及脂代谢基因在淋巴水肿患者中的表达情况[D].广州:暨南大学,2018.
[41] FU M R,CONLEY Y P,AXELROD D,et al.Precision assessment of heterogeneity of lymphedema phenotype,genotypes and risk prediction[J].Breast,2016,29:231-240.
[42] JELTSCH M,KAIPAINEN A,JOUKOV V,et al.Hyperplasia of lymphatic vessels in VEGF-C transgenic mice[J].Science,1997,276:1423-1425.
[43] MEESKE K A,SULLIVAN-HALLEY J,SMITH A W,et al.Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women[J].Breast Cancer Res Treat,2009,113(2):383-391.
[44] DISIPIO T,RYE S,NEWMAN B,et al.Incidence of unilateral arm lymphoedema after breast cancer:a systematic review and meta-analysis[J].Lancet Oncology,2013,14(6):500-515.
[45] 王洪波,郑静.乳腺癌术后患侧上肢淋巴水肿防治探讨[J].现代仪器与医疗,2017(2):41-43.
[46] 刘军,王伟,陈成玲.乳腺癌术后上肢淋巴水肿的危险因素分析[J].肿瘤学杂志,2018,24(1):70-73.
[47] 王玲,李惠萍,王本忠.乳腺癌术后上肢淋巴水肿危险因素的研究现状[J].中华肿瘤防治杂志,2012,19(13):1036-1040.
[48] CAL A,BAHAR Z.Women's barriers to prevention of lymphedema after breast surgery and home care n eeds:aqualitative study[J].Cancer Nurs,2016,39(6):E17-E25.
[49] 朱薇.健康教育联合信息支持疗法在乳腺癌术后预防上肢淋巴水肿的护理研究[J/OL].实用临床护理学电子杂志,2020,5(25):195.
[50] 范奕送,李桂宝,陈雄芬,等.协同干预模式结合微信圈提高乳腺癌改良术后患者功能锻炼依从性研究[J].中国医药科学,2017,7(11):93-96.
[51] 杨璇,张海林,孙文雯.乳腺癌相关淋巴水肿发病风险的研究进展[J].护理学杂志,2018,33(23):98-101.
[52] PUSIC A L,CEMAL Y,ALBORNOZ C,et al.Quality of life among breast cancer patients with lymphedema:a systematic review of patient-reported outcome instruments and outcomes[J].J Cancer Surviv,2013,7(1):83-92.
[53] JEFFS E,REAM E,SHEWBRIDGE A,et al.Exploring patient perception of success and benefit in self-management of breast cancer-related arm lymphoedema[J].Eur J Oncol Nurs,2016,20:173-183.
[54] CZERNIEC S A,WARD I C,Kilbreath S L.Breast cancer-related arm lymphedema:fluctuation over six months and the effect of the weather[J].Lymphat Res Biol,2016,14(3):148-155.
[55] 刘煜仲,解丽娟,王蓓.飞机旅行与乳腺癌术后淋巴水肿关联性的Meta分析[J].护理研究,2020,34(10):1835-1837.
[56] ZIMMERMANN A,WOZNIEWSKI M,SZKLARSKA A,et al.Efficacy of manual lymphatic drainage in preventing secondary lymphedema after breast cancer surgery[J].Lymphology,2012,45(3):103-112.
[57] 王玲.乳腺癌患者术后淋巴水肿风险评分系统的构建和评价[D].合肥:安徽医科大学,2013.
[58] 杨璇.乳腺癌相关淋巴水肿发生风险等级预测模型的研究[D].南京:南京医科大学,2019. |
